![Daniel J. Meichelbock](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel J. Meichelbock
Gestore di Portafoglio-Azioni presso MH & Associates Securities Management Corp.
Profilo
Mr. Daniel J.
Meichelbock is a Vice President & Portfolio Manager at MH & Associates Securities Management Corp.
Mr. Meichelbock joined the firm on a full time basis in January of 2000.
Combined with his previous experience, he has amassed over 20 years of experience in the area of financial analysis.
He has applied a particular focus on market timing and technical analysis.
Mr. Meichelbock joined Bradley Pharmaceuticals as a sales representative upon graduation.
He graduated from the University of California at Los Angeles (UCLA) in 1997 with a Bachelors in Economics.
In February 2015, Mr. Meichelbockearned the designation of Accredited Portfolio Management Advisor (APMA) from the College for Financial Planning.
Posizioni attive di Daniel J. Meichelbock
Società | Posizione | Inizio |
---|---|---|
MH & Associates Securities Management Corp.
![]() MH & Associates Securities Management Corp. Investment ManagersFinance MH & Associates Securities Management Corp. (MH & Associates) is an independent, SEC-registered investment advisor headquartered in Carlsbad, California. The firm was founded by J. Robert Meichelbock and John Heilman in 1981. MH & Associates provides investment management services to families, companies and institutions. | Gestore di Portafoglio-Azioni | 01/01/2000 |
Precedenti posizioni note di Daniel J. Meichelbock
Società | Posizione | Fine |
---|---|---|
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Corporate Officer/Principal | - |
Formazione di Daniel J. Meichelbock
University of California, Los Angeles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
MH & Associates Securities Management Corp.
![]() MH & Associates Securities Management Corp. Investment ManagersFinance MH & Associates Securities Management Corp. (MH & Associates) is an independent, SEC-registered investment advisor headquartered in Carlsbad, California. The firm was founded by J. Robert Meichelbock and John Heilman in 1981. MH & Associates provides investment management services to families, companies and institutions. | Finance |
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Health Technology |
- Borsa valori
- Insiders
- Daniel J. Meichelbock